Today, Singapore is home to more than 50 biomedical sciences manufacturing plants, producing a wide range of products ranging from drugs to medical devices and equipment, with a combined manufacturing output of more than $26 billion in 2014. With over 30 leading biomedical sciences companies basing their regional headquarters here, Singapore is also a key base for companies to access the fast-growing Asia-Pacific markets.

Download the report here